SYS-CON MEDIA Authors: Yeshim Deniz, Peter Silva, Glenn Rossman, Ava Smith, Elizabeth White

News Feed Item

The Zacks Analyst Blog Highlights:JPMorgan, Pfizer, Coca-Cola, Johnson & Johnson and IBM

CHICAGO, April 21, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the JPMorgan (NYSE:JPM-Free Report), Pfizer Inc. (NYSE:PFE-Free Report), Coca-Cola Company (NYSE:KO-Free Report), Johnson & Johnson (NYSE:JNJ-Free Report) and IBM Corp. (NYSE:IBM-Free Report).

Zacks Investment Research, Inc., www.zacks.com

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday's Analyst Blog:

Dow 30 Stock Roundup

The Dow notched up substantial gains during a holiday shortened week, boosted by several positive factors. Promising retail sales data propelled the blue chip index upward on Monday.

The Dow index gained again on Tuesday following upbeat quarterly results from key components. Encouraging industrial production numbers and China data egged on the blue chip index on Wednesday. Comments from the Fed Chair added to the positive sentiment. During the first three trading days, the Dow has gained 1.56%.

Last Week's Performance

The Dow dropped 0.9% last Friday, hit by another day of selling pressure in bio-tech and technology stocks. Disappointing corporate earnings also weighed on the markets.

Dismal corporate earnings results from JPMorgan (NYSE:JPM-Free Report) led the decline among the Dow components after its shares plunged 3.7%. Higher wholesale prices in March and an increase in preliminary consumer sentiment in April failed to restrict the day's losses.

For the week, the blue-chip index ended 2.3% lower, snapping a three-week run of gains. Benchmarks declined for the week due to intense selling pressure in momentum and technology stocks. Additionally, discouraging Chinese trade data unnerved investors.

Pfizer Inc. (NYSE:PFE-Free Report) was a big drag at the start of the week. The stock led the decline among the Dow components on Monday. Shares of the company were down almost 3% after its breast-cancer drug palbociclib did well in clinical trials but the overall survival benefits was not yet revealed to be statistically significant. However, on Wednesday, benchmarks soared, primarily boosted by encouraging minutes from the central bank's policy meeting.

The Dow Last Week

Encouraging retail sales data helped the Dow gain 0.9% on Monday. The U.S. Department of Commerce reported that seasonally adjusted sales of retail and food services rose 1.1% in March, its biggest gain since September 2012. The gain was led by the increase in demand for auto sales. Sales of motor vehicles jumped 3.1%, its biggest rise since September 2012. Investors also remained focused on recent developments in Ukraine.

The Dow gained 0.6% on Tuesday after blue-chip companies The Coca-Cola Company (NYSE:KO-Free Report) and Johnson & Johnson (NYSE:JNJ-Free Report) reported upbeat quarterly results. CPI improved 0.2% in March, higher than the consensus estimate of a 0.1% increase. The Empire State Manufacturing Index fell to 1.3 in April from 5.6 in March. This fall was in sharp contrast to the consensus estimate of a rise to 8.1. The day's mixed economic data had little impact on benchmarks.

Markets finished in the green on Wednesday, primarily boosted by encouraging industrial production data and better-than-expected Chinese economic data. Industrial production improved 0.7% in March after advancing 1.2% in February. Additionally, China's GDP increased 7.4% in the first quarter, more than the analysts' expectation of an increase by 7.3%. Fed Chairwoman Janet Yellen's speech in New York was another positive factor yesterday. The Dow gained substantially, by 1%.

Components Which Moved the Index

IBM Corp. (NYSE:IBM-Free Report) reported disappointing revenues in the first quarter of 2014, which missed the Zacks Consensus Estimate for the fifth straight quarter. However, earnings of $2.54 per share were in line with the Zacks Consensus Estimate.

Earnings per share declined 15.3% from the year-ago quarter and a massive 58.6% from the previous quarter due to lower revenue base and steep increase in total operating expenses.

The weaker-than-expected first-quarter results are expected to hurt IBM's ability to achieve fiscal 2014 earnings target of $18.00 per share. Shares declined 4.2% ($8.20) in after-hours trading yesterday.

The Coca-Cola Company started 2014 on a positive note, beating the Zacks Consensus Estimate for revenues in the first quarter while meeting earnings expectations as volumes gained slightly. This is the first time that Coca-Cola has beaten the Zacks Consensus Estimate for sales in the past six quarters. Shares were up 2% in pre-market trading on Tuesday.

First-quarter 2014 adjusted earnings came in at 44 cents per share, in line with the Zacks Consensus Estimate. Earnings declined 4% on a year-over-year basis due to currency headwinds as a strong dollar lowered the value of the company's ex-U.S. sales. Earnings grew 5% year over year on a constant currency basis as positive price/mix gains, strong developing market volumes and cost control made up for higher marketing costs.

Johnson & Johnson, the first among the large health care companies to report first quarter results, beat expectations yet again. The company's first-quarter 2014 earnings (excluding special items) were $1.54 per share, well above the Zacks Consensus Estimate of $1.48 per share and 6.9% above the year-ago earnings of $1.44 per share.

Despite the negative impact of currency fluctuation, Johnson & Johnson recorded growth on the back of strong pharma product sales. Johnson & Johnson's first quarter sales increased 3.5% year-over-year to $18.1 billion, just above the Zacks Consensus Estimate of $17.9 billion.

While operational factors favorably impacted sales by 5.3%, currency fluctuations had a negative impact of 1.8%.Including one-time items, Johnson & Johnson reported first quarter earnings of $1.64 per share, well above the year-ago earnings of $1.22.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.

Get the full Report on JPM - FREE

Get the full Report on PFE - FREE

Get the full Report on KO - FREE

Get the full Report on JNJ - FREE

Get the full Report on IBM - FREE

Follow us on Twitter: http://twitter.com/zacksresearch

Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

[email protected]

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Logo - http://photos.prnewswire.com/prnh/20101027/ZIRLOGO  

SOURCE Zacks Investment Research, Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories

ARMONK, N.Y., Nov. 20, 2014 /PRNewswire/ --  IBM (NYSE: IBM) today announced that it is bringing a greater level of control, security and flexibility to cloud-based application development and delivery with a single-tenant version of Bluemix, IBM's

DevOps Summit 2015 New York, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is obsolete...
"There is a natural synchronization between the business models, the IoT is there to support ,” explained Brendan O'Brien, Co-founder and Chief Architect of Aria Systems, in this SYS-CON.tv interview at the 15th International Cloud Expo®, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"Our premise is Docker is not enough. That's not a bad thing - we actually love Docker. At ActiveState all our products are based on open source technology and Docker is an up-and-coming piece of open source technology," explained Bart Copeland, President & CEO of ActiveState Software, in this SYS-CON.tv interview at DevOps Summit at Cloud Expo®, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Focused on this fast-growing market’s needs, Vitesse Semiconductor Corporation (Nasdaq: VTSS), a leading provider of IC solutions to advance "Ethernet Everywhere" in Carrier, Enterprise and Internet of Things (IoT) networks, introduced its IStaX™ software (VSC6815SDK), a robust protocol stack to simplify deployment and management of Industrial-IoT network applications such as Industrial Ethernet switching, surveillance, video distribution, LCD signage, intelligent sensors, and metering equipment...
C-Labs LLC, a leading provider of remote and mobile access for the Internet of Things (IoT), announced the appointment of John Traynor to the position of chief operating officer. Previously a strategic advisor to the firm, Mr. Traynor will now oversee sales, marketing, finance, and operations. Mr. Traynor is based out of the C-Labs office in Redmond, Washington. He reports to Chris Muench, Chief Executive Officer. Mr. Traynor brings valuable business leadership and technology industry experti...
What do a firewall and a fortress have in common? They are no longer strong enough to protect the valuables housed inside. Like the walls of an old fortress, the cracks in the firewall are allowing the bad guys to slip in - unannounced and unnoticed. By the time these thieves get in, the damage is already done and the network is already compromised. Intellectual property is easily slipped out the back door leaving no trace of forced entry. If we want to reign in on these cybercriminals, it's hig...
The 3rd International @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The Internet of Things (IoT) is the most profound change in personal and enterprise IT since the creation of the Worldwide Web more than 20 years ago. All major researchers estimate there will be tens of billions devices - computers, smartphones, tablets, and sensors - connected to th...
The Internet of Things is not new. Historically, smart businesses have used its basic concept of leveraging data to drive better decision making and have capitalized on those insights to realize additional revenue opportunities. So, what has changed to make the Internet of Things one of the hottest topics in tech? In his session at @ThingsExpo, Chris Gray, Director, Embedded and Internet of Things, discussed the underlying factors that are driving the economics of intelligent systems. Discover ...
Cochlear Limited, the global leader in implantable hearing solutions, has selected AppZero for easy migration of its Microsoft Windows Server 2003 applications, a major priority for IT organizations before Microsoft ends support on July 14, 2015. AppZero software enables server application migration from old operating systems to new platforms or clouds and has been proven to be ten times faster, more reliable and efficient than alternative approaches.
Fundamentally, SDN is still mostly about network plumbing. While plumbing may be useful to tinker with, what you can do with your plumbing is far more intriguing. A rigid interpretation of SDN confines it to Layers 2 and 3, and that's reasonable. But SDN opens opportunities for novel constructions in Layers 4 to 7 that solve real operational problems in data centers. "Data center," in fact, might become anachronistic - data is everywhere, constantly on the move, seemingly always overflowing. Net...
SYS-CON Media announced today the IBM, which offers the world’s deepest portfolio of technologies and expertise that are transforming the future of work, has launched ad campaigns on SYS-CON’s numerous online magazines such as Cloud Computing Journal, DevOps Journal, Virtualization Journal, and IoT Journal. IBM's campaigns focus on application testing, improving application development processes, common challenges in testing composite applications, continuous testing as part of the DevOps lifec...
Infor has announced a new feature Infor CloudSuite™ Aerospace & Defense (A&D) to aid compliance with International Traffic in Arms Regulations (ITAR). The ITAR function will serve as a complementary function for new or existing Infor CloudSuite A&D customers, to facilitate compliance for Infor customers that are creating a US defense article or performing a US defense service and wish to benefit from cloud-services. The ITAR regulation serves to manage handling and access requirements for dat...
To manage complex web services with lots of calls to the cloud, many businesses have invested in Application Performance Management (APM) and Network Performance Management (NPM) tools. Together APM and NPM tools are essential aids in improving a business's infrastructure required to support an effective web experience... but they are missing a critical component - Internet visibility. Internet connectivity has always played a role in customer access to web presence, but in the past few years u...
In her General Session at 15th Cloud Expo, Anne Plese, Senior Consultant, Cloud Product Marketing, at Verizon Enterprise, focused on finding the right mix of renting vs. buying Oracle capacity to scale to meet business demands, and offer validated Oracle database TCO models for Oracle development and testing environments. Anne Plese is a marketing and technology enthusiast/realist with over 19+ years in high tech. At Verizon Enterprise, she focuses on driving growth for the Verizon Cloud platfo...